8.37 -0.50 (-5.68%)
GTXI
Stock Details
Last Trade:8.37 Change:-0.50 (-5.68%) Prev Close:8.87 Open: 8.81 Days Range:8.36 – 9.18 52 Week Range: 8.06 - 20.20 Volume:228949 P/E: N/AEPS:-1.39
View AllRecent Alerts 07/04/09
Recent Alert on 06/01/09 at 8:53am
GTx's (GTXI) Toremifene 80 Mg Increased Bone Mineral Density In Prostate Cancer Patients on Androgen Deprivation Therapy
GTx's (GTXI) Toremifene 80 Mg Increased Bone Mineral Density In Prostate Cancer Patients on Androgen Deprivation Therapy
GTx, Inc. (Nasdaq: GTXI) announced the presentation yesterday of data demonstrating that toremifene 80 mg treatment compared to placebo increased bone mineral density (BMD) in multiple clinically relevant subpopulations of men with prostate cancer... Read More
Recent Alert on 06/01/09 at 8:53am
GTx's (GTXI) Toremifene 80 Mg Increased Bone Mineral Density In Prostate Cancer Patients on Androgen Deprivation Therapy
GTx's (GTXI) Toremifene 80 Mg Increased Bone Mineral Density In Prostate Cancer Patients on Androgen Deprivation Therapy
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 04/28/09 at 5:58am
FDA, Clinical Trial Updates: GTx, XenoPort and GlaxoSmithKline, Rockwell Medical
FDA, Clinical Trial Updates: GTx, XenoPort and GlaxoSmithKline, Rockwell Medical

